Medtronic issued an urgent field safety notice regarding the potential for the Mazor X Surgical System with Positioner Type II to detach from the O.R. table unexpectedly.
Carmell Therapeutics announced FDA clearance of an Investigational New Drug application for the company’s Bone Healing Accelerant and enrollment in a pivotal study for long bone fractures.
Johnson & Johnson, parent to DePuy Synthes Companies, entered into an agreement to acquire the remaining ownership stake in Verb Surgical. The transaction is expected to close in 1H20.
Exactech appointed Mr. Darin Johnson as President and Chief Executive Officer, successor of Mr. David Petty, who will transition from CEO to Vice Chairman of the company's board of directors. Co-founders Bill Petty, M.D. and Betty Petty are retiring after 35 years at the company.
Episurf Medical received an additional patent in China relative to the Episealer® Femoral Twin joint implant design process and expects to obtain CE Mark Approval for the Episealer Talus ankle implant.
Seikagaku and Ono Pharmaceutical submitted a new drug application for manufacturing and marketing approval for ONO-5704/SI-613 injectable in Japan for the treatment of OA.
PERCEIVE3D was granted two new patents protecting its surgical navigation technology that combines video-based tracking with Augmented Reality to provide guidance in arthroscopic and open orthopedic surgery.